Analysis: Indonesia's textile rescue: Revival or another failed SOE?

Indonesia’s sovereign wealth fund, Danantara, has pledged to contribute at least 100 million dollars annually to the Danantara Indonesia Trust. This commitment supports philanthropic initiatives focused on health, education, and sanitation. The pledge was announced on Thursday to mark the first anniversary of the trust. During the ceremony, officials also unveiled three new collaboration programs involving the Ministry of Health, Plan Indonesia, and four state universities. Rosan Roeslani, the chief executive officer of Danantara, stated that the organization is dedicated to disbursing this minimum amount each year. He explained that the funding aims to expand social impact while building Indonesian philanthropic institutions capable of contributing globally. Roeslani emphasized that the programs will prioritize good governance, transparency, and accountability. The trust has committed to submitting comprehensive reports annually and providing updates to the public on a quarterly basis. A major component of the partnership involves the Ministry of Health. One priority project provides specialist medical education scholarships for 1,343 doctors. These grants cover both educational expenses and living costs during the study period. The initiative seeks to alleviate the shortage of specialist physicians, particularly in regions with limited access to medical professionals. Minister of Health Budi Gunadi Sadikin welcomed the formation of the trust and the associated financial support. He noted that the assistance will accelerate several national health programs. Specifically, 200 billion rupiah, equivalent to roughly 10.8 million dollars, will fund a human papillomavirus vaccination campaign. This program targets cervical cancer prevention, a leading cause of cancer deaths among women in Indonesia. Sadikin stated that cervical cancer claims nearly 30,000 lives yearly. The new funding is expected to shorten the planned implementation duration of the vaccination drive from 15 years to between five and 10 years. Additionally, 600 billion rupiah, or approximately 32.6 million dollars, has been approved for a specialist doctor scholarship scheme. This portion focuses on training medical personnel in treating high-mortality conditions such as stroke and heart disease. Doctors from remote areas will receive educational support and funding for three to four years. The condition attached to this aid is that recipients must return to their home regions to strengthen local healthcare services. Sadikin expressed hope that the trust’s support would yield sustainable improvements in the health and well-being of the Indonesian population. Beyond these specific health initiatives, the broader context of Danantara’s operations includes strategic industrial interventions. President Prabowo Subianto has directed the establishment of a new state-owned enterprise to revive the struggling textile sector. This plan potentially utilizes assets from the bankrupt textile giant Sritex. The move responds to factory closures, mass layoffs, and intense competition from cheaper imports, notably from China. Roeslani indicated that the government intends to create a vertically integrated textile company rather than injecting capital into existing firms. Industry reactions have been mixed. Some stakeholders welcome the intervention to strengthen the domestic supply chain, while others fear increased competition in a market already plagued by weak demand and excess capacity. Data indicates that production capacity utilization ranges from 45 percent in the fiber segment to 58 percent in garments. This suggests many manufacturers operate well below potential output. The Indonesian Textile Association describes the industry as encompassing interconnected segments, from upstream synthetic fiber production to downstream garment manufacturing. Although the country possesses established capacity in many downstream activities, it relies on imported inputs for certain upstream processes. The effectiveness of the new state-owned entity will depend on its position within this value chain. Critics argue that adding a new producer might exacerbate existing overcapacity issues if current manufacturers cannot fully utilize their facilities. The government faces the challenge of determining whether a new state actor can restore competitiveness or if it will further complicate an already fragile industrial landscape.